Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|1|31-37

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.1, 2015-01, pp. : 31-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of Apoptosis via the Modulation of Reactive Oxygen Species (ROS) Production in the Treatment of Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-01 ,pp. : 323-329

Bentham Science Publishers

Access to resources Recommend Favorite

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3677-3692

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer

By Verschoor Meghan L.   Wilson Leigh A.   Singh Gurmit  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 3, 2010-03 ,pp. : 204-219

NRC Research Press

Access to resources Recommend Favorite

Ischemia-Reperfusion Injury of the Cochlea: Pharmacological Strategies for Cochlear Protection and Implications of Glutamate and Reactive Oxygen Species

By  

Current Neuropharmacology, Vol. 8, Iss. 2, 2010-06 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite

New Pathways for Reactive Oxygen Species Generation in Inflammation and Potential Novel Pharmacological Targets

By  

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1647-1652

Bentham Science Publishers

Access to resources Recommend Favorite